Previous studies have shown that c-Myc is overexpressed [35] and functions as a proto-oncogene in AML [36],[37]; here, we show that inhibiting CCN1 down-regulated c-Myc protein expression. The gene discussed is MYC; the disease is acute myeloid leukemia.